Your browser doesn't support javascript.
loading
Manifestations Reported by Inflammatory Bowel Disease Patients in University Hospital.
Jonaityte, Ieva Renata; Karpaviciute, Vita; Kiudelis, Gediminas; Kupcinska, Juozas; Jonaitis, Laimas.
Afiliación
  • Jonaityte IR; Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Karpaviciute V; Center of Dermatovenerology, Vilnius University Hospital Santaros klinikos, Vilnius, Lithuania.
  • Kiudelis G; Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Kupcinska J; Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Jonaitis L; Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Acta Med Litu ; 31(1): 177-186, 2024.
Article en En | MEDLINE | ID: mdl-38978848
ABSTRACT

Background:

Inflammatory bowel disease (IBD) may affect organs outside the intestines, it is called extraintestinal manifestations of IBD. Data on the prevalence of mu-cocutaneous manifestations in IBD patients are very limited, therefore, the aim of this study was to assess the prevalence of skin and mucosal lesions and to determine the relationship with demographic factors, clinical features, and systemic treatment. Materials and

methods:

Prospective study included 162 out-patients with IBD who were managed in the tertiary care center. Ulcerative colitis (UC) was diagnosed in 117 patients, Crohn's disease (CD) in 45. Patients completed the questionnaire containing demographic and IBD data, questions about mucocutaneous lesions (in past or present state).

Results:

Overall mucocutaneous lesions were reported by 48.1% of IBD patients. Skin lesions were reported by 40.7% of patients, oral mucosal lesions were reported by 16.7%, without significant differences between sexes or IBD types. In 47 (29%) of patients, skin lesions appeared together with IBD or during the course of the disease. The most common skin lesions were psoriasis (8.0%), erythema nodosum (5.6%), pyoderma gangrenosum and acne (3.7% each). UC patients mostly reported about psoriasis (9.4%), while CD patients about erythema nodosum (11.1%). There were more frequent skin lesions in patients with more extensive UC type (p = 0.01), while no difference was noticed between different types of CD. The average duration of IBD in patients with skin lesions was similar to those without lesions (9.3±6.7 vs. 9.4±6.7 years).

Conclusions:

Mucocutaneous lesions were reported by 48.1% of inflammatory bowel disease patients. The frequency of mucocutaneous lesions does not differ significantly between UC and CD, and a longer duration of illness is not a predictive factor for the appearance of lesions. More extensive UC is related to higher frequency of skin lesions.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Acta Med Litu Año: 2024 Tipo del documento: Article País de afiliación: Lituania Pais de publicación: Lituania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Acta Med Litu Año: 2024 Tipo del documento: Article País de afiliación: Lituania Pais de publicación: Lituania